You are here

Nkarta Therapeutics

Nkarta goes back to basics

EP Vantage

Tue, 06/27/23 - 10:07 am

Nkarta Therapeutics

natural killer cell therapy

With new data, Nkarta builds case for ‘natural killer’ cell therapy

BioPharma Dive

Mon, 12/5/22 - 10:45 am

Nkarta Therapeutics

natural killer cell therapies

Nkarta keeps natural killer therapy ball rolling with plans for new San Francisco headquarters, manufacturing site

Fierce Pharma

Wed, 07/14/21 - 10:48 am

Nkarta Therapeutics

natural killer cells

Can we freeze them? Yes we can, says Nkarta

EP Vantage

Mon, 02/15/21 - 10:26 am

natural killer cell therapy

Nkarta Therapeutics

3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments

Xconomy

Mon, 07/13/20 - 11:33 pm

Nkarta Therapeutics

Poseida Therapeutics

Another four biotechs scratch out the first number and ask for more as IPO boom continues

Endpoints

Fri, 07/10/20 - 11:00 am

Relay Therapeutics

Nkarta Therapeutics

Poseida Therapeutics

Trying to turn 'natural killers' against cancer, Nkarta raises $114 million

Bizjournals

Thu, 09/5/19 - 10:10 am

Nkarta Therapeutics

natural killer cells